Trithiocarbonates—Exploration of a new head group for HDAC inhibitors

Bioorganic & Medicinal Chemistry Letters
2007.0

Abstract

Inhibition of histone deacetylases class I/II enzymes is a new, promising approach for cancer therapy. In the present study, we disclose a new structural class of HDAC inhibitors with the trithiocarbonate motif. A clear structure-activity-relationship was obtained for the cap-linker motif and the putative Zn(2+) complexing head group. Selected analogs display potent inhibition of HDAC enzymatic activity and a cellular potency comparable to that of suberoylanilide hydroxamic acid (SAHA), recently approved for treatment of patients with advanced cutaneous T-cell lymphoma.

Knowledge Graph

Similar Paper

Trithiocarbonates—Exploration of a new head group for HDAC inhibitors
Bioorganic & Medicinal Chemistry Letters 2007.0
Trithiocarbonates as a Novel Class of HDAC Inhibitors: SAR Studies, Isoenzyme Selectivity, and Pharmacological Profiles
Journal of Medicinal Chemistry 2008.0
Synthesis and structure–activity relationship of histone deacetylase (HDAC) inhibitors with triazole-linked cap group
Bioorganic & Medicinal Chemistry 2008.0
Benzothiazole-containing hydroxamic acids as histone deacetylase inhibitors and antitumor agents
Bioorganic & Medicinal Chemistry Letters 2011.0
Design, synthesis, and activity of HDAC inhibitors with a N-formyl hydroxylamine head group
Bioorganic & Medicinal Chemistry Letters 2004.0
Novel Inhibitors of Human Histone Deacetylases:  Design, Synthesis, Enzyme Inhibition, and Cancer Cell Growth Inhibition of SAHA-Based Non-hydroxamates
Journal of Medicinal Chemistry 2005.0
Thiol-based SAHA analogues as potent histone deacetylase inhibitors
Bioorganic & Medicinal Chemistry Letters 2004.0
Improved antiproliferative activity of 1,3,4-thiadiazole-containing histone deacetylase (HDAC) inhibitors by introduction of the heteroaromatic surface recognition motif
Bioorganic & Medicinal Chemistry 2014.0
SelSA, selenium analogs of SAHA as potent histone deacetylase inhibitors
Bioorganic & Medicinal Chemistry Letters 2010.0
Histone deacetylase inhibitors with a primary amide zinc binding group display antitumor activity in xenograft model
Bioorganic & Medicinal Chemistry Letters 2009.0